Linkages between DA neurodegeneration and microglial neuroinflammatory activities are well-known and demonstrated by large numbers of immune-competent microglia within the substantia nigra of postmortem PD brains (7) appearing as phagocytic cells engulfing damaged DA neurons (7,8). In transgenic mutant ␣-syn mice and in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone (8 -10), similar microglial responses are operative. Importantly, such microglial activation is associated with ␣-syn deposition (11-13) and internalization (14). This occurs throughout disease, suggesting linkages to oxidative damage, ␣-syn nitration and aggregation, and PD-associated neurodegeneration (15, 16) Indeed, microglial activation is strongly associated with neurotoxic responses and collateral neuronal damage (17)(18)(19)(20). Thus, for PD, nitrated-␣-syn (N-␣-syn)-mediated microglial activation and accelerated neuronal death are closely related (21-25).Abundant evidence indicates a significant role for adaptive immunity in neuroregulatory activities (26 -29). Such effects are seen in experimental neurodegenerative models, including PD (29 -31). Principally, these data found that neuronal degeneration or protection is linked to the microglial phenotype and that N-␣-syn-specific effector T cells exacerbate microglial activation and DA neurodegeneration, whereas CD4 ϩ
CD25ϩ regulatory T cells (Treg) attenuate those processes; however, how microglia activation is regulated by regulatory and effector T cell subsets is not known. To address this, we used aggregated N-␣-syn as an inducer of microglial activation (23, 24), then studied the microglial immune response as it is affected by activated Treg and CD4 ϩ
CD25Ϫ effector T cells (Teff). The observations demonstrate, for the first time, that Treg modulate a broad range of microglial activities, including redox biology, migration, phagocytosis, energy metabolism, and cytokine secretions. Differential outcomes of microglial processes are dependent on the temporal engagement of Treg with N-␣-syn and microglia. The findings provide insights into disease pathobiology and how the adaptive immune system may be harnessed for therapeutic benefit.